Acknowledgements
Hideo Kimura(Yantai University), Alba Di Pardo(Istituto Neurologico Mediterraneo), Brunangelo Falini(University of Perugia), Fiorina Giona(Sapienza University of Rome), G. Bordin, P. Baglioni, Kohji Matsuyama, N. Saoudi Gonzalez, Marco Gobbi, Nadia Cecconi, R. Gilgal, M.G. Mazzucconi, M.T. Rivano(University of Bologna), P. Zigrossi, M. Djaldetti, Shin Matsuda, Anna Baldi, Brain D. Smith, L. Ruocco(Azienda Ospedaliera Universitaria Pisana), D Fernández-Garese, E. Martinelli, David Fitzpatrick, F.A. Lukanmbi, G. Roy, Tohru Ohkoshi, Peter H. Fishman, Adekunle Adekile(Kuwait University), Tatsumi Uchida, Alessandra Marini(Leibniz Institute of Environmental Medicine), Jane Liesveld, Bruno Grassi, A. Ferrari, Ernesto D. Hendler, Seiji Kojima, Yoshihisa Kodera(Aichi Medical University), J.M. Fernández-Rañada(Spanish Society of Hematology and Hemotherapy), Antonio Azzarà, Cornelius Cronin, Şînasi Özsoylu, Fabio Ambrogi, I Zahavi, R. Arranz(Hospital Universitario de La Princesa), I. J. Temperley, Lawrence R. Solomon, A Monteverde, S Kariyone, S. Pileri, Bola O.A. Osifo
Cited by 0
Related Papers
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
|New England Journal of Medicine|2005|1.9k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
|Blood|2005|703
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569